This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Product Information
DEXTROAMP-AMPHETAM 7.5 MG TAB is a generic product labeled by Lannett Company Inc., priced at $0.2612 per EA under NDC 00527076137. Its NADAC has been published 150 times since Oct 11, 2023.
FDA first approved this application on Jul 8, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAM 7.5 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine SulfateStrength
1.875; 1.875; 1.875; 1.875 mg/1; mg/1; mg/1; mg/1
Manufacturer
Lannett Company Inc.NDC
00527076137
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA215565FDA Approved
7/8/2022
TE Code
AB
On Market Since
7/8/2022
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has been published 150 times since Oct 11, 2023, and over the history we have for it it has declined 52.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2612 per EA |
|---|---|
| All-time high | $0.6705 (Nov 15, 2023) |
| All-time low | $0.1857 (Nov 20, 2024) |
| 52-week high | $0.3257 |
| 52-week low | $0.2582 |
| Median price | $0.3070 |
| Average price | $0.3455 |
| Largest weekly change | +57.3% (Dec 18, 2024) |
| Weeks tracked | 150 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAM 7.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 7.5 MG TAB, manufactured by Lannett Company Inc., is $0.2612 per EA (NDC 00527076137), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAM 7.5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has declined 52.6%. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 7.5 MG TAB?
Since Oct 11, 2023, the NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has ranged from a low of $0.1857 (Nov 20, 2024) to a high of $0.6705 (Nov 15, 2023), with a median of $0.3070 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAM 7.5 MG TAB?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAM 7.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHETAM 7.5 MG TAB?
DEXTROAMP-AMPHETAM 7.5 MG TAB (NDC 00527076137) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Is DEXTROAMP-AMPHETAM 7.5 MG TAB in shortage?
Yes — NDC 00527076137 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).